ET on Tuesday, shares of the continuous glucose monitoring giant DexCom (NASDAQ: DXCM) were down by 5.95%, the telemedicine services company Teladoc Health (NYSE: TDOC) saw its stock decline by 6.75%, and the healthcare-software company Veeva Systems (NYSE: VEEV) was lower by 3.55%. According to the report, the Consumer Price Index rose by an unsightly 8.3% in August relative to the same period a year ago. Wall Street is deeply concerned that red-hot inflation will curtail consumer spending in 2023, even for vital goods and services such as diabetes care, doctor visits, and clinical studies for important new drugs.